FDA Approves First Gene Therapy to Treat Adults with Metastatic Synovial Sarcoma

SILVER SPRING, Md., Aug. 2, 2024 /PRNewswire/ — Today, the U.S. Food and Drug Administration approved Tecelra (afamitresgene autoleucel), a gene therapy indicated for the treatment of adults with unresectable or metastatic synovial sarcoma who have received prior chemotherapy, are HLA…